Le Lézard
Classified in: Health
Subjects: PDT, MAT

Columbia Care Selected by Virginia Board of Pharmacy


PORTSMOUTH, Va., Dec. 11, 2018 /PRNewswire/ -- The City of Portsmouth, VA is proud to report that New York-based Columbia Care, one of the country's leading medical cannabis companies, has received approval and license from the State of Virginia to produce cannabis oil. The company, recently valued at $1.35 billion, is planning to open its dispensary in Portsmouth, Virginia in the spring of 2019. Columbia Care will cultivate, produce and dispense cannabidiol (CBD) and tetrahydrocannabinolic acid (THC-A) oil, capsules and creams prescribed to state-registered patients in the state.

Patients suffering from the chronic pain of arthritis, related symptoms of multiple sclerosis, spinal cord injuries, epilepsy, cancer and other diseases will now have access to CBD and THC-A products. Research has shown that medical cannabis can also provide relief from nausea and insomnia. Columbia Care operates dispensaries in Arizona, Massachusetts, New York, Illinois, California, Delaware, Pennsylvania, Maryland, Florida, Puerto Rico and Washington. Portsmouth Mayor John L. Rowe, Jr. said, "Columbia Care chose Portsmouth for its Virginia headquarters because of the city's access to the interstate and because of its readily available industrial space." Nicholas Vita, chief executive officer of Columbia Care stated, "We intend to develop a state-of-the-art pharmaceutical processing facility capable of surpassing the rigorous processing requirements outlined by the Board of Pharmacy, as we have successfully done in multiple other states."

"Columbia Care locating to Portsmouth demonstrates the state's commitment to scientific research to find cures and treatment for so many debilitating ailments," said Robert Moore, director for Portsmouth's Economic Development Department. Moore added that the company will initially have about 24 employees including chemists, scientists, horticulturalists and dispensers. "The Columbia Care facility will be staffed by a team of professionals trained to provide the highest level of compassion, confidentiality and respect for patients," stated Moore.

"Columbia Care has a proven track record of working effectively with the medical and research communities, providing a superior patient experience and producing products worthy of selection. I am honored to serve on Columbia Care Virginia's advisory board, and I look forward to helping the Company advance its mission of improving the lives of patients and their families by developing the highest-quality cannabinoid-based medicines and delivering the best care to the community at large," said Dr. Marissa Levine, former Virginia State Health Commissioner and co-chair of the Columbia Care Virginia Advisory Board.

Additional Columbia Care Virginia advisory board members include:


Basil Gooden, Ph.D., former Virginia secretary of agriculture

David Creecy, PharmD, former president of the Virginia Pharmacists Association

Tim Musselman, PharmD, former executive director of the Virginia Pharmacists Association

Reverend Tyrone Nelson, Henrico County board of supervisors Calvin Butts, Hampton University board of trustee

Terron Sims II, prominent U.S. veterans advocate

Lisa Smith, leading Virginia medical cannabis patient advocate

For Columbia Care company background and information, visit www.col-care.com which contains the healthcare company's mission, the leadership team and its other locations across the U.S. For more information, contact Robert D. Moore with the city of Portsmouth at 757-393-8804.

CONTACT: Sharon R. Hoggard Marketing Manager Department of Marketing, Communications & Tourism 757-393-5143 [email protected]

SOURCE City of Portsmouth, VA


These press releases may also interest you

at 05:29
SmartCella Holding AB today announces that Dr Ricardo Baptista has been appointed Chief Technology Officer (CTO) and Head of Procella. Ricardo is an experienced Biochemical Engineer with almost 20-years of global experience in the medical...

at 05:15
Every year in Quebec, more than 2,000 young people leave the care of the Director of Youth Protection (DYP) as they approach the age of majority. For youth under the care of the DYP, turning 18 means having to become independent quickly, with little...

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...



News published on and distributed by: